Comparative safety of transvenous and leadless pacemakers in patients with cardiovascular diseases: A meta-analysis study. Posted on January 30th, 2025 by LEADconnection Post navigation Previous: Prevalence of cardiac implantable electronic device infections in Germany in 2015.Next: Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry.
Prevalence of cardiac implantable electronic device infections in Germany in 2015. Posted on January 30th, 2025 by LEAD connection Post navigation Previous: Cardiac resynchronization therapy by pacing the right ventricular dorsal site of inflow and anterior outflow for congenitally corrected transposition of the great arteries: a case report.Next: Comparative safety of transvenous and leadless pacemakers in patients with cardiovascular diseases: A meta-analysis study.
Cardiac resynchronization therapy guided by interventricular conduction delay: How to choose between biventricular pacing or conduction system pacing. Posted on January 29th, 2025 by LEADconnection Post navigation Previous: Subxiphoid Insertion of a Pediatric Implantable Pulse Generator in a Neonate With Congenital Complete Heart Block.Next: Cardiac resynchronization therapy by pacing the right ventricular dorsal site of inflow and anterior outflow for congenitally corrected transposition of the great arteries: a case report.